Analysis of neutralizing antibodies to COVID-19 inactivated or subunit recombinant vaccines in hospitalized patients with liver dysfunction.

Hu Li, Shiyin Li,Pan Xu,Xiaohao Wang,Huan Deng,Yu Lei,Shan Zhong

Frontiers in immunology（2023）

引用 1|浏览13

暂无评分

摘要

NAbs response to COVID-19 inactivated or subunit recombinant vaccines was waning in patients with liver dysfunction. Moreover, patients with male sex, severe liver injury and chronic liver diseases have an increased risk of poor antibody responses.

查看译文

关键词

COVID-19,SARS-CoV-2,artificial liver,liver dysfunction,neutralizing antibodies,vaccine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要